The Top 25 MedTech Executives of 2025

The Healthcare Technology Report is pleased to announce The Top 25 MedTech Executives of 2025. Representing a range of companies—from AI-driven startups to global MedTech leaders—this year’s awardees reflect the sector’s shift toward more connected, technology-enabled care. Many are focused on long-standing challenges like joint degeneration, cardiovascular disease, diabetes, and neurological emergencies, using tools that combine hardware and software in new ways. Others are developing robotics platforms, advanced diagnostics, and minimally invasive therapies that expand access and reduce the burden on traditional care systems. As the MedTech industry is set to reach over $629 billion this year, these leaders are driving the future of healthcare through innovations that directly address the needs of both patients and providers.

This year’s awardees include leaders like Peter Arn of ROMTech, whose rehabilitation platform is helping patients recover from joint surgery up to 50% faster, Daniel Perez of Hinge Health, whose AI-powered solution has reduced pain and helped avoid thousands of unnecessary surgeries and opioid prescriptions, and Vikram Ahuja of OsseoLabs, where AI and 3D printing are enabling personalized surgical tools tailored to each patient’s anatomy. Across the cohort, these executives are making a tangible difference in patient care.

Carefully selected based on their leadership, innovation, and measurable contributions to the MedTech industry, this year’s awardees are positioned as key figures in advancing healthcare technology. Their work is setting new standards in the development and application of medical devices, digital health solutions, and patient care systems. Please join us in recognizing The Top 25 MedTech Executives of 2025.

1. Daniel Perez
Company: Hinge Health
Title: Co-Founder and CEO

Daniel Perez is the Co-Founder and CEO of Hinge Health, a medical technology company aiming to transform pain care and prevention by combining cutting-edge technology, AI, and expert clinical teams to deliver personalized treatment directly through users’ phones. By connecting people with digital and in-person care, Hinge Health helps reduce pain by 68%, prevent 42% of new opioid prescriptions, and avoid over half of joint replacement surgeries. 

Perez and his co-founder, Gabriel Mecklenburg, were inspired to start Hinge Health following their personal frustrations with the physical rehabilitation process following musculoskeletal injuries. Now, Hinge Health is trusted by top employers and health plans—including Verizon, Salesforce, and Land O’Lakes—and the platform covers 30 million members across more than 2,300 clients. In May 2025, the company successfully went public, signalling continued interest in the digital health space.

Previously, Perez founded and served as CEO of the Oxbridge Biotech Roundtable, a global platform that brings together academic and industry innovators to advance ideas in the life sciences and healthcare sectors. Before that, he co-founded and served as CEO of Marblar, a healthcare product development company. Perez earned a PhD in biochemistry from the University of Oxford and a bachelor’s degree in biology from Westminster University.

2. Peter Arn
Company: ROMTech
Title: CEO, Co-Founder, Chairman

Peter Arn is the CEO, Co-Founder, and Chairman of ROMTech. He first joined the company in 2014 as part of global sales and investor relations. ROMTech is the developer of a patented medical technology designed to revolutionize knee and hip rehabilitation. By enabling patients to recover up to 50% faster, the company’s innovative solution delivers significant benefits across the healthcare ecosystem—accelerating recovery times, reducing costs for patients and medical facilities, and improving outcomes for payors. 

An experienced entrepreneur, Arn has driven ROMTech’s core initiatives from day one, including product development, hiring, fundraising, and more. Prior to ROMTech, Arn served in various executive roles at four early-stage companies. Through his leadership, Arn has raised more than $20 million dollars in startup funding, developed robust sales channels, and has piloted multiple startups to profitable exits.

Previously, Arn co-founded and was part of the management team for multiple companies, including Calvin Capital Corporation, Hoffman Financial Group, GoChuckGo, and LIFERA Inc. Earlier in his career, he worked with Ross Mortgage Co. as a loan officer.

3. Helen Giza
Company: Fresenius Medical Care
Title: CEO

Helen Giza is the CEO and Chair of the Management Board at Fresenius Medical Care, a leading provider of products and services for individuals with renal diseases. The company is committed to creating a future worth living for chronically and critically ill patients. With decades of experience in dialysis, innovative research, and a value-based care approach, Fresenius Medical Care aims to help patients enjoy the best possible quality of life. 

Giza has more than 30 years of experience leading across healthcare services, MedTech, and pharmaceuticals. Throughout her career, she has led global transformations, revitalized underperforming businesses, and created long-term value for shareholders and stakeholders alike. Her focus is on driving strategic growth, building high-performing cultures, and navigating complex, highly regulated environments. She has a deep background in financial restructuring, capital markets, and corporate governance.

Giza joined Fresenius Medical Care in 2019 as chief financial officer and later took on the additional role of chief transformation officer. Previously, she served as chief integration and divestiture management officer at Takeda Pharmaceuticals. Before joining the Takeda Corporate Executive Team, she served as CFO of Takeda’s U.S. business unit. Earlier in her career, she held a number of key international finance and controlling positions, among others at TAP Pharmaceuticals and Abbott Laboratories. Giza is a UK Chartered Certified Accountant and holds an MBA from the Kellogg School of Management at Northwestern University.

4. Scott Drake
Company: Cordis
Title: CEO

Scott Drake is the CEO of Cordis and has served on the Cordis Board of Directors since 2021. Cordis has a legacy of over 60 years in cardiovascular innovation, starting with the development of the first guidewire and drug-eluting stent. Today, the company continues to advance in the interventional space through in-house development, its CordisX innovation incubator, and strategic acquisitions of emerging technologies. With a global presence, Cordis focuses on improving clinical outcomes, customer services, and educational initiatives to advance cardiovascular care.

Drake has over 30 years of medical device experience. He is driven by his passion for patient care and developing new approaches to improving patients’ quality of life. He has a reputation for creating a clear strategic vision and attracting world-class talent. As Executive Chairman, Drake supports Cordis and Cordis-X as they deliver a business model that aims to bring value to patients, clinicians, teammates, and shareholders. 

Previously, Drake served as the president and CEO of the Spectranetics Corporation, where he increased shareholder value from approximately $170 million to $2.2 billion during his six-year tenure. Drake has served on numerous boards of directors, including Zayo Group Holdings, which Digital Colony and EQT acquired for $14.3 billion, Bolder Surgical, the Medical Device Manufacturers Association, and he has served as the Chairman of Atricure, Inc. Currently, Drake serves on the Board of Directors of ViewRay, Inc. Drake earned a bachelor’s degree in business administration, management, and operations from Miami University of Ohio.

5. Ashley McEvoy
Company: Insulet
Title: President and CEO

Ashley McEvoy is the President and Chief Executive Officer of Insulet, a medical device company dedicated to improving the lives of people with diabetes through its Omnipod Insulin Management System. Founded in 2000 and based in Acton, Massachusetts, Insulet is a market leader in insulin pump therapy, committed to expanding access to user-friendly, tubeless insulin delivery. With a strong focus on innovation, customer experience, and purpose-driven care, Insulet aims to transform diabetes management for people around the world. 

McEvoy is the former executive vice president and worldwide chairman of MedTech at Johnson & Johnson, where she oversaw the company’s surgery, orthopaedics, interventional solutions, and eye health businesses. Prior to that, she served as company group chairman for consumer medical devices and for vision and diabetes care. McEvoy also led J&J’s global suture products business as worldwide president of Ethicon Products. McEvoy brings to Insulet a breadth of leadership, strategy, and risk management experience from her previous roles, where she led significant and diverse businesses with a global footprint, driving strategic investments in innovation platforms and commercial executions that delivered significant growth.

Since 2023, McEvoy has been a member of the Procter & Gamble Board of Directors, where she serves on the Compensation & Leadership Development and Innovation & Technology Committees. She previously served on the Board of Trustees for the Children’s Hospital of Philadelphia. She graduated from the University of Pennsylvania with a bachelor’s degree in communications and business.

6. Ivan Tornos
Company: Zimmer Biomet
Title: Chairman, President, and CEO

Ivan Tornos is the Chairman, President, and Chief Executive Officer of Zimmer Biomet, a global medical technology leader offering a comprehensive portfolio of solutions designed to maximize mobility and improve health. The company advances its mission to alleviate pain and enhance the quality of life for patients worldwide through innovative products and a suite of integrated digital and robotic technologies that leverage data, analytics, and artificial intelligence. Founded in 1927 and headquartered in Warsaw, Zimmer Biomet operates in more than 25 countries and sells its products in over 100 countries. 

Tornos joined Zimmer Biomet as group president of orthopedics, and a year later was named group president of global businesses and the Americas. He was appointed as chief operating officer in 2021, with responsibility for overseeing all global businesses of the company, as well as leading the global operations, clinical and medical education, global R&D, and new product development functions.

Tornos brings over three decades of global experience in medical devices, diagnostics, biotechnology, and pharmaceuticals, having worked with Fortune 50 to 500 companies, MedTech start-ups, and incubator projects. He has a proven track record in business development, P&L management, and B2B strategy. Prior to joining Zimmer Biomet, Tornos served as worldwide president of the global urology, medical, and critical care division at Becton, Dickinson and Company. Prior to that, he was with C.R. Bard in positions of increasing responsibility, most recently serving as president of the EMEA region. Earlier in his career, he spent over a decade in leadership assignments around the globe at Johnson & Johnson.

Tornos graduated from the advanced management program at Harvard Business School and also completed leadership and management programs at the Cox School of Business at Southern Methodist University. He completed post-MBA work at the Wharton School, holds an MBA from the University of Miami School of Business, and a bachelor’s degree in finance and international marketing and management from the University of Georgia Terry College of Business. Tornos serves on the Board of Directors of the Advanced Medical Technology Association and as an independent member of the Board of Directors of PHC Holdings Corporation.

7. Michael Mahoney
Company: Boston Scientific
Title: Chairman and CEO

Mike Mahoney is the Chairman and Chief Executive Officer of Boston Scientific, a global medical technology leader with approximately $16.7 billion in annual revenue and commercial representation in more than 127 countries. Boston Scientific aims to transform lives through innovative medical technologies that improve health outcomes for patients worldwide. For over 40 years, the company has advanced science by delivering high-performance solutions that address unmet medical needs and help reduce healthcare costs. Its portfolio of devices and therapies supports physicians in diagnosing and treating complex cardiovascular, respiratory, digestive, oncological, neurological, and urological conditions.

Since joining Boston Scientific, Mahoney has focused the company on addressing the needs of the evolving healthcare landscape by driving improvements to patient outcomes and increasing healthcare economic efficiency and access. Under his leadership, Boston Scientific has brought many transformational medical devices to market while creating significant value for its shareholders.

Mahoney’s career spans more than 25 years of success building market-leading medical device, capital equipment, and healthcare IT businesses. Prior to Boston Scientific, he served as worldwide chairman of the medical devices and diagnostics division of Johnson & Johnson. Prior to joining Johnson & Johnson, Mahoney was president and CEO of Global Healthcare Exchange (GHX). Mahoney serves on the Board of CVS Health and the Boys & Girls Club of Boston, and is the chair of the Board of Governors of the Boston College CEO Club. He earned his bachelor’s degree in finance from the University of Iowa and his MBA from Wake Forest University. 

8. Devdatt Kurdikar
Company: embecta
Title: President and CEO

Devdatt Kurdikar serves as the President and Chief Executive Officer of embecta. embecta (formerly part of BD) is a global medical technology company singularly focused on improving the lives of people living with diabetes. With a 100-year legacy of innovation and dedication to the diabetes community, embecta is a leader in insulin delivery devices. Today, more than 30 million people in over 100 countries rely on the company’s pen needle and syringe products.

Kurdikar has a proven track record of value creation, combining a strong strategic mindset with a focus on execution. He is committed to developing high-performing teams and fostering a winning culture. With extensive experience leading capital equipment, disposables, and implantables businesses within both public and private equity structures, Kurdikar has successfully transformed businesses and facilitated sales to strategic acquirers at attractive valuations.

Previously, Kurdikar was the President and CEO of Cardiac Science Corporation (CSC), a global leader in the manufacturing and marketing of automated external defibrillators for public access, education, police, and fire and rescue markets. Kurdikar is currently a member of the Board of Directors of Zimmer Biomet Holdings, Inc., AdvaMed, and LMG Holdings. He holds a bachelor’s degree in chemical engineering from the University of Bombay, a master’s degree in chemical engineering from Washington State University, a PhD in chemical engineering from Purdue University, and an MBA from Washington University.

9. Sunny Sanyal
Company: Varex Imaging
Title: CEO

Sunny Sanyal is the CEO of Varex Imaging Corp., a Utah-based public company that designs and manufactures critical components of systems for medical and industrial imaging applications globally. The company has operations in the U.S., Germany, the Netherlands, Sweden, Finland, China, and the Philippines. Varex Imaging Corporation is the world’s largest independent supplier of medical X-ray tubes and image processing solutions, serving a broad range of applications from medical diagnostics to cargo screening and border security. 

Sanyal has nearly 30 years of experience in global healthcare technology, services, and medical devices, with a proven track record of driving growth. He has held C-level leadership roles in software, hardware, and service companies within MedTech and diagnostic imaging, overseeing organizations ranging from $50 million to over $2 billion in sales and 200 to more than 6,000 employees across operations in the U.S., Europe, and Asia.

Prior to his role at Varex, Sanyal held leadership positions as president of Varian Medical Systems’ Imaging Components Division, CEO of T-System Inc., president of McKesson Provider Technologies, and vice president and general manager of clinical information systems at GE HealthCare. Sanyal holds a bachelor’s degree in electrical engineering from the University of Mumbai, a master’s degree in industrial engineering from Louisiana State University, and an MBA from Harvard University.

10. John Sheridan
Company: Tandem Diabetes Care
Title: President and CEO

John Sheridan is the President and Chief Executive Officer of Tandem Diabetes Care, Inc., a medical device company specializing in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company designs, manufactures, and markets advanced automated insulin delivery systems. Its solutions are built to reduce the burden of diabetes management while creating new possibilities for individuals living with diabetes, their loved ones, and healthcare providers. 

Sheridan has extensive leadership experience spanning both large multinational corporations and growing start-ups, where he has built trust with executive teams and boards. His strengths include leading the commercialization of complex technologies, developing organizations and systems to support business goals, and delivering predictable financial results. Over the last 15 years, he has led operations and R&D for both medical device and high-tech companies, driving commercial success in fast-paced, innovative environments.

Prior to joining Tandem Diabetes Care, Sheridan served as chief operating officer of Rapiscan Systems, Inc., a provider of security equipment and systems. Before that, he served as executive vice president of research and development and operations for Volcano Corporation. Earlier in his career, he served as vice president of operations at Digirad Corporation, a medical imaging company. Sheridan holds a bachelor’s degree in chemistry from the University of West Florida and an MBA from Boston University.

11. Suzanne Winter
Company: Accuray
Title: President and CEO

Suzanne Winter is the President and CEO of Accuray, bringing more than 30 years of healthcare medical technology experience. Accuray designs radiotherapy solutions aimed at addressing complex challenges while simplifying treatment for more common cases. The company’s technologies provide radiation therapy across a variety of patient needs, with a global presence that extends its practices worldwide. Focused on continuous innovation, Accuray works to improve patient care and quality of life while addressing diverse healthcare needs around the globe.

Winter joined Accuray as senior vice president and chief commercial officer in 2019. Prior to joining Accuray, Winter held senior executive roles spanning general management, commercial, and business development across a range of healthcare industry segments, including diagnostic imaging, cardiovascular, neurocritical care, and surgery. Most recently, she served as vice president of the Americas at Medtronic, where she was responsible for the $1.4 billion Americas region and led a 2,000-person commercial organization. Before Medtronic, Winter was the general manager of GE Healthcare’s interventional, x-ray, and mammography business.

Winter earned an MBA from the Harvard University Graduate School of Business and a bachelor’s degree in chemistry from Saint Lawrence University.

12. Xingjuan (Jane) Chao
Company: Ceribell
Title: President, Chief Executive Officer, Co-Founder, and Director

Jane Chao is the President, Chief Executive Officer, Co-Founder, and Director of Ceribell. Headquartered in Sunnyvale, California, Ceribell is a medical technology company aiming to transform the diagnosis and management of serious neurological conditions. Its Ceribell System—a novel, FDA 510(k)-cleared, point-of-care EEG platform—combines portable hardware with AI-powered algorithms to enable rapid diagnosis and continuous monitoring of patients in acute care settings. Currently used in ICUs and emergency rooms across the U.S., Ceribell aims to establish its system as the standard of care for EEG.

Chao brings 16 years of experience to her current role. Prior to joining Ceribell, Chao served as a principal manager of portfolio management strategy at Genentech, Inc., a biotechnology company. Prior to that, she served as senior strategy manager at Novartis AG. Earlier in her career, Chao served as an engagement manager at McKinsey & Company. Chao also previously served on the board of directors of Magnus Medical, Inc., a medical equipment company. She holds a bachelor’s degree in chemistry from Peking University and a PhD in biophysics from Cornell University.

13. Lucy O’Keeffe
Company: CroíValve
Title: Co-Founder and CEO

Lucy O’Keeffe is the Co-Founder and CEO of CroíValve, a Dublin-based early-stage medical device company focused on developing a best-in-class, minimally invasive transcatheter solution for the treatment of severe tricuspid regurgitation (TR).TR is a condition that significantly impacts mortality, cardiovascular outcomes, and quality of life, particularly in patients over 65, where it is more prevalent than aortic stenosis. CroíValve combines clinical, technical, and commercial expertise to address this unmet clinical need in the field of structural heart innovation. 

O’Keeffe brings 19 years of experience to her current role. She has extensive experience leading medical device development programs and leading global teams and programs to develop a range of solutions, including transcatheter aortic heart valves, drug delivery devices, and technology for clinical trials. She has a proven track record in global project management, medical device development, risk management, and budget planning, with expertise in people management, design control, technical data analysis, and business development.

O’Keeffe previously worked as a cross-functional lead at Medtronic, managing R&D programs from concept to launch, including an early transcatheter aortic program. Additionally, she worked at Nypro Healthcare, managing multiple complex, cross-functional, global projects developing drug delivery devices for top-tier pharmaceutical clients. O’Keeffe holds a bachelor’s degree in mechanical engineering from University College Dublin, a PhD in biomedical engineering from the University of Limerick, and a diploma in applied project management from University College Cork.

14. Shon Chakrabarti
Company: LimFlow
Title: Chief Medical Officer

Shon Chakrabarti is the Chief Medical Officer of LimFlow, a division of Inari Medical. LimFlow is a medical device company specializing in the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease that often leads to amputation when conventional treatments fail. The minimally invasive LimFlow System is designed to bypass blocked arteries in the leg and deliver oxygenated blood back into the foot via the veins in CLTI patients who are facing major amputation and have exhausted all other therapeutic options.

Chakrabarti has spent over 25 years learning about the human body and how technology can improve lives. His journey began with studying chemical engineering at the University of Michigan, followed by training with top interventional cardiologists and clinical investigators at Harvard Medical School. He then practiced medicine, caring for a community of patients in coastal Virginia. Today, Chakrabarti works alongside innovators to help bring new technologies to the very patients he once treated.

Before joining LimFlow, Chakrabarti served as vice chief of medicine at Chesapeake Regional Healthcare. He then went on to serve as medical director and later, director of clinical research and medical affairs at Abiomed. Before becoming CMO of LimFlow, Chakrabarti was vice president of medical affairs and vice president and general manager of chronic venous therapies at Inari Medical. He holds a bachelor’s degree in chemical engineering from the University of Michigan and a master’s degree in public health from the Harvard T.H. Chan School of Public Health.

15. Jhonatan Bringas Dimitriades
Company: Lapsi Health
Title: Co-Founder and CEO

Jhonatan Bringas Dimitriades is the Co-Founder and CEO of Lapsi Health. The company focuses on advancing auscultation by transforming heartbeats and breaths into digital biomarkers that support real-time health decisions. Using innovative technology and a flexible hardware architecture, Lapsi captures vital sounds to deliver precise, actionable data. The Sound (Auscultation) platform is designed for both healthcare professionals and individuals, enabling informed health actions and improving outcomes.

With over a decade of experience in clinical medicine, occupational medicine, digital health, and medical management, Dimitriades is passionate about revolutionizing the use of auscultatory sounds in digital medicine. His leadership at Lapsi Health aims to create solutions that enhance diagnosis, monitoring, and therapy across a variety of conditions. In addition to his role at Lapsi, he serves as a Digital Health Transformation Advisor for Clínica Internacional, one of the largest private care systems in Latin America, guiding the implementation of digital solutions to improve healthcare efficiency and workflows.

Dimitriades began his career in 2011 as a general practitioner in several private hospitals and clinics. He later served at Policía Nacional del Perú before becoming a digital health education advisor at Medscape. Throughout his career, he has held leadership roles, including business director, medical director, and chief medical officer at healthtech and digital health companies across Europe and the U.S. He has also advised numerous companies and institutions. Dimitriades graduated from the University of Havana with an MD and studied occupational medicine at the Universidad Nacional de Trujillo.

16. Doug Ward
Company: Lumos Diagnostics
Title: CEO

Doug Ward is the CEO of Lumos Diagnostics, a company specializing in rapid, cost-effective point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions more accurately. The company offers customized assay development and manufacturing services, proprietary digital reader platforms, and also develops and commercializes its own Lumos-branded POC tests targeting infectious and inflammatory diseases.

Ward has held numerous executive positions, including CEO, during his more than 30-year career. Most recently, he served as vice president of strategy and business development at Hologic, where he led a global team responsible for fostering innovation in women’s healthcare to improve clinical results. He has demonstrated success in raising capital, building organizations, creating enterprise value, and obtaining domestic and international regulatory approvals, with a deep understanding of the complex and fast-moving life sciences ecosystem.

Ward first got his start in 1988 as an account representative at Ciba Corning Diagnostics. From there, he went on to Chiron Corporation, where he held various roles, including national business director. He later served as vice president of marketing at Bayer HealthCare and as general manager and president of the Americas at GE Healthcare Life Sciences, where he turned around business growth. Ward was previously the VP and GM of companion diagnostics at Ventana Medical Systems, where he led the creation of the companion diagnostic business unit. Ward graduated from Ohio Wesleyan University with a bachelor’s degree in pre-medical studies.

17. Jose Amich
Company: Zeta Surgical
Title: Co-Founder and CEO

Jose Amich is the Co-Founder and CEO of Zeta Surgical. Based in Boston, Massachusetts, Zeta Surgical is a company that develops surgical navigation and robotics tools designed to simplify, accelerate, and expand access to minimally invasive surgeries. Focused on advancing next-generation surgical technologies, Zeta Surgical is conducting a clinical trial on AI-enabled cranial navigation in partnership with the National Neuroscience Institute.

Amich brings seven years of experience to his current role. Before joining Zeta Surgical, Amich was a research fellow at Harvard Medical School, where he conducted cell biology research under the direction of Professor Joan Brugge, the Louise Foote Pfeiffer Professor of Cell Biology. Amich graduated from the MIT Sloan School of Management with an MBA and from Harvard University with a bachelor’s degree in cellular and molecular biology.

18. Ángel Alberich-Bayarri
Company: Quibim
Title: Founder and CEO

Ángel Alberich-Bayarri is the Founder and CEO of Quibim. Quibim designs pioneering tools that unlock imaging data to improve patient outcomes. The company is known for transforming imaging data into actionable predictions. Its main purpose is to apply AI techniques to medical images, including MRI, CT, and PET, to extract new data that can be transformed into actionable predictions for life sciences and healthcare providers. 

Alberich-Bayarri brings 23 years of experience to his current role. As CEO and founder of Quibim, he leads a team of professionals dedicated to designing pioneering tools that unlock imaging data to improve patient outcomes. With over 15 years of experience in medical imaging and computer vision, Alberich-Bayarri has a deep understanding of the challenges and opportunities in diagnostics and drug development, driving innovation and advancing the company’s mission in the healthcare space.

Before joining Quibim, Alberich-Bayarri led scientific-technical direction at the Biomedical Imaging Research Group (GIBI2^30) at the Instituto de Investigación Sanitaria La Fe and, before that, was a biomedical engineering coordinator in the Department of Research-Development-Innovation and Teaching at Grupo Hospitalario Quirón. Earlier in his career, he worked with Universidad Politécnica de Valencia (UPV) as a telecommunications engineer. Alberich-Bayarri graduated from UPV with a PhD in biomedical engineering.

19. Jim Cloar
Company: Aspen Medical Products
Title: President and CEO

Jim Cloar is the President and CEO of Aspen Medical Products. Aspen Medical Products is a leading innovator in the design, development, and marketing of upper and lower spinal orthotics. Headquartered in Irvine, California, with a global network of sales representatives, Aspen has spent 30 years delivering groundbreaking spinal bracing solutions to the healthcare market. 

Cloar brings 40 years of experience to his role at Aspen. He is known for his expertise in driving business growth and innovation, having led Aspen’s expansion into new markets through strategic acquisitions like Advanced Orthopaedics in 2023 and ProMedics in 2019. He is deeply involved in product development and has a rich background leading growth and expansion in orthopedic organizations.

Before joining the company in 2020, Cloar served as president at ZimmerBiomet Spine, focusing on expanding the company’s spinal solutions portfolio. He also held the role of chief commercial officer at Synaptive Medical, managing global sales and marketing strategies, and has held management roles at Medtronic, DePuy Orthopaedics, and Smith & Nephew.  Cloar graduated from Georgetown College with a bachelor’s degree in business.

20. Eric Timko
Company: OrthAlign
Title: Chairman and CEO

Eric Timko is the Chairman and CEO of OrthAlign. Driven by the belief that everyone deserves exceptional healthcare, OrthAlign is committed to making empowering technologies accessible. As a leader in simple, smart technology for joint surgery, OrthAlign provides advanced micro-electromechanical sensor-based solutions that offer live-navigation for partial knee, total knee, and total hip replacements using any surgical approach. The company’s technology is clinically proven, cost-effective, and easy to integrate, delivering precision and accessibility in orthopedic care.

Timko has over 25 years of experience in the medical industry. Most recently, he was president and CEO of Blue Belt Technologies, which was later acquired by Smith & Nephew. Timko joined Blue Belt in 2011 and led the company from the development stage to a commercially driven organization that achieved over $10 million in revenues in its first full year of commercialization. Prior to joining Blue Belt, Timko served as president and CEO of NeuroVasx, Inc., president of Carl Zeiss Surgical, Inc., and vice president of Siemens Medical Systems, Inc.

Timko possesses a proven track record in building an effective and profitable organization and brings vast experience in medical technologies at both the start-up and commercial stages and across many specialties such as orthopedics, neurosurgery, and ophthalmology. He also serves on the Boards of iotaMotion, Nico Corporation, and the Palmetto Chapter of the Folds of Honor Foundation. Timko studied at Kent State University.

21. Yoona Kim
Company: Arine
Title: Co-Founder and CEO

Yoona Kim is the Co-Founder and CEO of Arine. Founded in 2017 and based in San Francisco, the company aims to transform medication-based care through its industry-leading software platform that combines cutting-edge AI, clinical expertise, and advanced data analytics. By delivering proactive, population-level interventions informed by real-time outcomes data, Arine offers a dynamic, value-based solution that enhances patient outcomes and reduces healthcare costs with precision and efficiency.

Previously, Kim was the head of clinical modeling and analytics at Proteus Digital Health, Inc., and before that, an associate director of global health economics and outcomes research at Gilead Sciences. Earlier in her career, she worked with Mercer as a health and benefits associate. Kim earned a Doctor of Pharmacy degree in health policy and management from the University of California, San Francisco, a PhD in health economics and outcomes from the University of Texas at Austin, and a bachelor’s degree in human biology from Stanford University.

22. Mark Grant
Company: Lifeward
Title: President and CEO

Mark Grant is the President and Chief Executive Officer of Lifeward, a medical technology company that designs, develops, and commercializes solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Its portfolio features products like the ReWalk Exoskeleton, the ReStore Exo-Suit, the MYOLYN FES bikes, and the AlterG Anti-Gravity systems.

As a leader with more than 25 years of experience in healthcare and medical technology, Grant has been critical in directing global business development and operations management by leveraging intuitive adaptability combined with disruptive leadership to drive continuous growth, transformation, and internal change management within start-ups, acquisitions, and multibillion-dollar businesses.

Previously, Grant spent nearly 20 years at Medtronic, where he served as the vice president of the diabetes business. During his time there, he led the $1.5 billion Americas region and a 2,000-person commercial organization. In his most recent role prior to Lifeward, he served as president of the Americas and chief commercial officer at IMRA Surgical and drove global market expansion and introduced new, innovative models for ethical soft tissue robotic surgical education. He earned his bachelor’s degree in industrial technology from East Carolina University. 

23. Shikha Anand
Company: Casana
Title: Chief Medical Officer

Shikha Anand is the Chief Medical Officer of Casana, having first joined the company in 2023. Casana aims to revolutionize healthcare delivery with the Heart Seat®, a smart, FDA-cleared toilet seat that enables effortless and consistent in-home health monitoring. By capturing vital signs such as heart rate and blood oxygenation, Casana provides integrated, actionable intelligence from the comfort of home.

Anand brings more than 20 years of experience evaluating and launching tools to help people improve their health in their homes and communities. Her leadership experience includes public health, research, consumer health technology, health equity, and clinical informatics. 

Prior to joining Casana, Anand served as the chief medical officer at Well, an on-demand healthcare guidance platform, and Withings, a leader in connected health technology. She has used her clinical, research, and data science expertise to lead initiatives to develop novel technology and algorithms to screen, diagnose, and monitor chronic medical and behavioral health conditions at these companies. She has also led health innovation initiatives at Federally Qualified Health Centers, Aetna/CVS, and Walmart’s Care Clinics.

Anand holds an MD from Albany Medical College, a master’s degree in public health from the Boston University School of Public Health, and a bachelor’s degree from Union College.

24. Scott Nelson
Company: FastWave Medical
Title: Co-Founder and CEO

Scott Nelson is the Co-Founder and CEO of FastWave Medical, a company advancing next-level intravascular lithotripsy (IVL) systems to treat calcific artery disease—a market valued at over $10 billion. With a remarkable pace of innovation, FastWave is developing cutting-edge IVL solutions designed to improve patient outcomes. Having successfully closed over $40 million in capital, the company is rapidly progressing toward its next key clinical and regulatory milestones, driving transformative impact in vascular health.

Nelson is also the founder of Medsider, where he interviews founders and CEOs of promising, early-stage medical device and health technology companies. As a MedTech growth architect, he founded and scaled Joovv to over $20 million in topline revenue in just a few years, and the company is now a category leader for in-home photobiomodulation devices. Prior to that, Nelson held various leadership roles at fast-growing startups and multinational strategics, including Touch Surgery, Medtronic, Covidien, Boston Scientific, and C.R. Bard. Nelson holds a bachelor’s degree in biology from Grand View University.

25. Vikram Ahuja
Company: OsseoLabs
Title: Co-Founder and CEO

Vikram Ahuja is the Co-Founder and CEO of OsseoLabs, a company pioneering the future of surgery by integrating advanced 3D printing technology and artificial intelligence to develop personalized medical devices tailored to each patient’s unique anatomy. With a focus on maxillofacial and orthopedic procedures, OsseoLabs delivers bespoke surgical solutions that enhance precision and improve patient outcomes.

Ahuja first got his start in 2008 as a process improvement and strategy associate at Krungthai Bank. From there, he went on to co-found and serve as CEO of hireQ.io. Before joining OsseoLabs, Ahuja co-founded and served as CEO of Nabsolute, a company developing biomedical solutions. Ahuja has also served as an educator at Indiana University’s Kelley School of Business, teaching MBA and undergraduate students.

Ahuja graduated from the Indiana University Kelley School of Business with a PhD in business and managerial economics and from Thammasat University with a bachelor’s degree in economics.